Cerenome (PSTV) Preferred Dividend Payments (2014 - 2019)
Plus Therapeutics (PSTV) posted quarterly Preferred Dividend Payments of $554000.0 for Q3 2019, down 77.72% year-over-year from $2.5 million in Q3 2018, and down 77.72% quarter-over-quarter from $2.5 million in Q3 2018.
Cerenome (PSTV) Preferred Dividend Payments (2014 - 2019) Analysis & Trends
Plus Therapeutics (PSTV) has reported Preferred Dividend Payments for 5 consecutive years, with $554000.0 the latest figure, recorded in Q3 2019.
- In Q3 2019, Preferred Dividend Payments fell 77.72% year-over-year to $554000.0; the TTM figure through Dec 2019 stood at $3.0 million (down 52.95% YoY), while the FY2019 annual figure was $554000.0, down 77.72% from the prior year.
- Preferred Dividend Payments eased to $554000.0 in Q3 2019 per PSTV's latest filing, from $2.5 million in the prior quarter.
- Across five years, Preferred Dividend Payments topped out at $4.0 million in Q4 2017 and bottomed at $554000.0 in Q3 2019.
- Historically, Preferred Dividend Payments has averaged $1.9 million across 4 years, with a median of $1.6 million in 2015.
- On a YoY basis, Preferred Dividend Payments climbed as much as 77.72% in 2019 and fell as far as 77.72% in 2019.
- Plus Therapeutics' Preferred Dividend Payments stood at $661000.0 in 2015, then surged by 501.66% to $4.0 million in 2017, then sank by 37.47% to $2.5 million in 2018, then tumbled by 77.72% to $554000.0 in 2019.
- Business Quant data shows PSTV's Preferred Dividend Payments at $554000.0 in Q3 2019, $2.5 million in Q3 2018, and $4.0 million in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref Dividends (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | - |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | - |
| 10 | Cerenome | 28.07 Mn | 19.48 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 554,000.00 |
| Sep 30, 2018 | 2.49 Mn |
| Dec 31, 2017 | 3.98 Mn |
| Mar 31, 2015 | 661,000.00 |
| Dec 31, 2014 | 1.17 Mn |